Form 4: Nuvalent CFO Sells Shares Under 10b5-1 Plan

Nuvalent's Chief Financial Officer, Alexandra Balcom, sold Class A Common Stock totaling 7,084 shares on December 8, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Alexandra Balcom, Nuvalent, Inc.'s Chief Financial Officer, reported the sale of Class A Common Stock.
• The transactions occurred on December 8, 2025.
• A total of 7,084 shares of Class A Common Stock were disposed of directly.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
• One transaction involved the sale of 6,984 shares at a weighted average price of $110.31, with prices ranging from $110.00 to $110.98.
• A second transaction involved the sale of 100 shares at a weighted average price of $111.32, with prices ranging from $111.22 to $111.42.
• Following these transactions, Alexandra Balcom beneficially owns 54,650 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider sale under a pre-arranged 10b5-1 trading plan, which is generally considered neutral as it's for personal financial management and not indicative of a change in company fundamentals.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating pre-scheduled transactions for personal financial management rather than a reaction to new, non-public information.

Negatives

• Insider sales, even under a 10b5-1 plan, can sometimes be perceived negatively by investors, though the pre-arranged nature mitigates this concern.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual's personal financial planning within the context of their role at a publicly traded company.

Stakeholder Impact

• Shareholders: May note the insider sale, but the 10b5-1 plan context suggests it's for personal financial planning rather than a negative signal about the company's prospects.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request from the SEC, Nuvalent, Inc., or any security holder.

Key Dates

Recommendation

The filing reports a routine insider sale by the CFO under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial management and do not inherently signal a change in the company's fundamental prospects or warrant a change in investment recommendation based solely on this filing.

Keywords

Nuvalent, NUVL, Form 4, insider trading, stock sale, CFO, Alexandra Balcom, 10b5-1 plan, equity securities